Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$16.69 - $26.05 $1.86 Million - $2.91 Million
-111,605 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$18.15 - $27.75 $89,751 - $137,223
-4,945 Reduced 4.24%
111,605 $2.82 Million
Q1 2021

May 17, 2021

SELL
$20.71 - $51.02 $1.73 Million - $4.26 Million
-83,425 Reduced 41.72%
116,550 $2.87 Million
Q4 2020

Feb 16, 2021

BUY
$21.84 - $44.0 $3.38 Million - $6.82 Million
154,975 Added 344.39%
199,975 $7.32 Million
Q3 2020

Nov 16, 2020

BUY
$13.63 - $24.12 $613,350 - $1.09 Million
45,000 New
45,000 $975,000
Q1 2020

May 15, 2020

SELL
$4.75 - $12.41 $773,209 - $2.02 Million
-162,781 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$8.73 - $12.95 $1.42 Million - $2.11 Million
162,781 New
162,781 $1.77 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $165M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Parian Global Management LP Portfolio

Follow Parian Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parian Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Parian Global Management LP with notifications on news.